News

According to a recent study, chest CT scans are able to identify bronchial or lung lesions in patients with systemic mastocytosis (SM).

Lupin Limited recently announced it has received approval from the FDA for its midostaurin 25 mg capsules to treat aggressive SM.

According to a recently-published article, increased knowledge and awareness of systemic mastocytosis is needed among specialists.

A recent study found a genetic association between the KIT M541L variant and mastocytosis—SM and CM, in particular.

Long COVID, which is also called long-term COVID or post-COVID syndrome, may be linked to mast cell activation syndrome (MCAS).

A recent report shows increased awareness of systemic mastocytosis (SM) is associated with fewer diagnostic delays, which leads to better patient care.

Blueprint medicines partnered with Twist Out Cancer to launch an art program that showcases what it’s like to live with systemic mastocytosis.

A recent study showed the standardization of screening and the use of diagnostic testing could improve ISM diagnosis rates.

A patient was diagnosed with aggressive SM due to findings from computerized tomography (CT) and contrast-enhanced PET scans.

A recent case report details a patient with mast cell leukemia (MCL), which authors state may be the rarest form of systemic mastocytosis (SM).